Mebeverine Hcl Aristo

Mebeverine Hydrochloride, the active ingredient in Mebeverine Hcl Aristo, is an antispasmodic (smooth muscle relaxant) presented as an oral dosage form for oral use. It is employed to relieve abdominal cramping and discomfort associated with irritable bowel syndrome and other functional bowel disorders in adult patients.

GNH USA supplies Mebeverine Hcl Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory‑compliant documentation for global distribution.

Mebeverine Hydrochloride acts on the gastrointestinal smooth‑muscle pathway to alleviate spasm‑related disorders. It is indicated for: - Irritable bowel syndrome: reduces abdominal pain, cramping and irregular bowel movements. - Functional bowel disorders: eases discomfort and normalises bowel habit. - Spastic colon: diminishes colonic muscle hyperactivity, improving patient quality of life.

Mebeverine Hydrochloride may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Dizziness: light‑headed sensation. - Constipation: decreased bowel frequency. - Abdominal discomfort: mild pain or bloating.

Serious or Rare Side Effects: - Allergic reaction: rash, itching or swelling. - Angioedema: swelling of face, lips or throat. - Severe skin eruption: Stevens‑Johnson‑like rash. - Cardiac arrhythmia: irregular heartbeat (very rare).

Before prescribing Mebeverine Hydrochloride, clinicians should consider the following precautions: - Assess renal function: adjust use in severe impairment. - Monitor hepatic function: use with caution in liver disease. - Evaluate for hypersensitivity: discontinue if allergic signs appear. - Review concomitant anticholinergic agents: may enhance antispasmodic effect. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Mebeverine Hydrochloride can interact with other medicines; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors: may increase mebeverine plasma concentrations. - Strong anticholinergic drugs: additive antispasmodic effect may cause excessive dryness.

Moderate Interactions (Monitor Closely): - Other antispasmodics: combined use may intensify muscle relaxation. - Antidepressants (SSRIs, SNRIs): may alter gastrointestinal motility. - Antihistamines: can increase dry‑mouth sensation. - Oral contraceptives: theoretical reduction in efficacy, monitor cycle regularity.